Bariatric/Metabolic Surgery and Type 2 Diabetes
10.4093/jkd.2019.20.3.136
- Author:
Jin Hwa KIM
1
Author Information
1. Department of Endocrinology and Metabolism, Chosun University Hospital, Gwangju, Korea. endocrine@chosun.ac.kr
- Publication Type:Review
- Keywords:
Bariatric surgery;
Diabetes mellitus, type 2
- MeSH:
Bariatric Surgery;
Comorbidity;
Diabetes Mellitus, Type 2;
Glucose;
Obesity;
Obesity, Morbid;
Prognosis;
Public Health
- From:Journal of Korean Diabetes
2019;20(3):136-141
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
When type 2 diabetes and obesity occur together, disease burden is increased and this is an important public health concern due to the deleterious effects. Despite continuing advances in pharmacological approaches to diabetes, diabetes still remains a chronic, progressive, and irreversible disease. Recently, bariatric surgery, initially developed to treat severe obesity, has attracted growing interest for its beneficial effects on improvement in glucose outcomes and type 2 diabetes remission. Several studies suggest considering this surgery as metabolic surgery because it leads to improvement in obesity-related metabolic comorbidities. The Diabetes Surgery Summit recently recommended inclusion of bariatric surgery among glucose-lowering interventions for type 2 diabetes and obesity. Bariatric surgery can be considered as one effective treatment option and may present an appropriate opportunity to improve prognosis in selected people with type 2 diabetes.
